Intero Biosystems
2 known investors
Find your way into Intero Biosystems
59 people in our graph share verified history with the Intero Biosystems team — schools, employers, funds. One of them is your warm intro.
Alexandra Farmerunlockedknows Charlie Childs · together at University of Michigan (overlapped)
×11knows the team · via University of Michigan
Interobio Systems develops stem-cell-derived human intestinal organoids that include functioning neurons, blood vessels, muscle, and intestinal lining for use in preclinical drug testing. The company applies human biology and organoid technology to support drug discovery and development.
Founders & leadership
CC
Charlie ChildsinCEOCharlie Childs is Head of AI Strategy at Intero Biosystems, which develops stem-cell-derived intestinal organoids for preclinical drug testing and discovery applications.30 Under 30 2026
ME
JS
Jason SpenceCSO
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountPre-SeedJun 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Intero Biosystems do?
- Interobio Systems develops stem-cell-derived human intestinal organoids that include functioning neurons, blood vessels, muscle, and intestinal lining for use in preclinical drug testing. The company applies human biology and organoid technology to support drug discovery and development.
- Who founded Intero Biosystems?
- Intero Biosystems was founded by Charlie Childs, Madeline Eiken, Jason Spence.
- Who are Intero Biosystems's investors?
- Intero Biosystems's investors include Houston Angel Network, Michigan Rise.